Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 280

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Bisphosphonate Associated Osteonecrosis of the Jaw

Open access
KHAN, ALIYA A., SÁNDOR, GEORGE K.B., DORE, EDWARD, MORRISON, ARCHIBALD D., ALSAHLI, MAZEN, AMIN, FAIZAN, PETERS, EDMUND, HANLEY, DAVID A., CHAUDRY, SULTAN R., LENTLE, BRIAN, DEMPSTER, DAVID W., GLORIEUX, FRANCIS H., NEVILLE, ALAN J., TALWAR, REENA M., CLOKIE, CAMERON M., MARDINI, MAJD AL, PAUL, TERRI, KHOSLA, SUNDEEP, JOSSE, ROBERT G., SUTHERLAND, SUSAN, LAM, DAVID K., CARMICHAEL, ROBERT P., BLANAS, NICK, KENDLER, DAVID, PETAK, STEVEN, STE-MARIE, LOUIS GEORGES, BROWN, JACQUES, EVANS, A.WAYNE, RIOS, LORENA, COMPSTON, JULIET E.·2009·The Journal of Rheumatology

Abstract

In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving bisphosphonates (BP) were published. These cases occurred in patients with cancer receiving high-dose intravenous BP; however, 5% of the cases were in patients with osteoporosis receiving low-dose bisphosphonate therapy. We present the results of a systematic review of the incidence, risk factors, diagnosis, prevention, and treatment of BP associated ONJ. We conducted a comprehensive literature search for relevant studies on BP associated ONJ in oncology and osteoporosis patients published before February 2008.All selected relevant articles were sorted by area of focus. Data for each area were abstracted by 2 independent reviewers. The results showed that the diagnosis is made clinically. Prospective data evaluating the incidence and etiologic factors are very limited. In oncology patients receiving high-dose intravenous BP, ONJ appears to be dependent on the dose and duration of therapy, with an estimated incidence of 1%–12% at 36 months of exposure. In osteoporosis patients, it is rare, with an estimated incidence < 1 case per 100,000 person-years of exposure. The incidence of ONJ in the general population is not known. Currently, there is insufficient evidence to confirm a causal link between low-dose BP use in the osteoporosis patient population and ONJ. We concluded BP associated ONJ is associated with high-dose BP therapy primarily in the oncology patient population. Prevention and treatment strategies are currently based on expert opinion and focus on maintaining good oral hygiene and conservative surgical intervention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3899/jrheum.080759

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 280

Metadata

Authors
KHAN, A. A., SÁNDOR, G. K. B., DORE, E., MORRISON, A. D., ALSAHLI, M., AMIN, F., PETERS, E., HANLEY, D. A., CHAUDRY, S. R., LENTLE, B., DEMPSTER, D. W., GLORIEUX, F. H., NEVILLE, A. J., TALWAR, R. M., CLOKIE, C. M., MARDINI, M. A., PAUL, T., KHOSLA, S., JOSSE, R. G., SUTHERLAND, S., LAM, D. K., CARMICHAEL, R. P., BLANAS, N., KENDLER, D., PETAK, S., STE-MARIE, L. G., BROWN, J., EVANS, A. W., RIOS, L., & COMPSTON, J. E.
Venue
The Journal of Rheumatology
Published
2009-03
Volume
36
Issue
3
Pages
478-490
ISSN
  • 0315-162X (ISSN-L)
  • 1499-2752
OpenAlex
W1994799035
Cited by
280
References
64
FWCI
16.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bisphosphonate Associated Osteonecrosis of the Jaw. https://app.cochat.ai/papers/10.3899/jrheum.080759
The paper
KHAN, A. A., SÁNDOR, G. K. B., DORE, E., MORRISON, A. D., ALSAHLI, M., AMIN, F., PETERS, E., HANLEY, D. A., CHAUDRY, S. R., LENTLE, B., DEMPSTER, D. W., GLORIEUX, F. H., NEVILLE, A. J., TALWAR, R. M., CLOKIE, C. M., MARDINI, M. A., PAUL, T., KHOSLA, S., JOSSE, R. G., . . . COMPSTON, J. E. (2009). Bisphosphonate Associated Osteonecrosis of the Jaw. The Journal of Rheumatology. https://doi.org/10.3899/jrheum.080759

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.